NCT04202783 is a NA clinical trial of Exosomes in Neuralgia, sponsored by Neurological Associates of West Los Angeles.

Who is sponsoring NCT04202783?

NCT04202783 is sponsored by Neurological Associates of West Los Angeles.

What drugs are being tested in NCT04202783?

Interventions in NCT04202783: Exosomes.

Is NCT04202783 still recruiting?

NCT04202783 is currently suspended. Last updated 28 September 2022.

Last reviewed 2022-09-28 · How we verify

NCT04202783

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Exosomes In Craniofacial Neuralgia

Suspended NA Last updated 28 September 2022

What this trial tests

NA trial testing Exosomes in Neuralgia in 100 participants. Suspended.

Timeline

1 December 2023

Primary endpoint
1 December 2024

1 December 2024

Quick facts

Lead sponsor	Neurological Associates of West Los Angeles
Phase	NA
Status	Suspended
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 December 2023
Primary completion	1 December 2024
Estimated completion	1 December 2024
Sites	1 location across United States

Drugs / interventions tested

Exosomes

Conditions studied

Neuralgia — all drugs for Neuralgia →

Sponsor

Neurological Associates of West Los Angeles

Who can join

18 and older, any sex, with Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to evaluate the safety and efficacy of exosome deployment in patients with Craniofacial Neuralgia. Secondarily, this study is designed to rigorously evaluate for any adverse events that may be related to the administration and reception of exosomes.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical applications of stem cell-derived exosomes.
Tan F, Li X, Wang Z, Li J, et al · · 2024 · cited 390× · PMID 38212307 · DOI 10.1038/s41392-023-01704-0
Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics.
Tenchov R, Sasso JM, Wang X, Liaw WS, et al · · 2022 · cited 336× · PMID 36354238 · DOI 10.1021/acsnano.2c08774
Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent.
Joo HS, Suh JH, Lee HJ, Bang ES, et al · · 2020 · cited 206× · PMID 31979113 · DOI 10.3390/ijms21030727
High-Intensity Focused Ultrasound: A Review of Mechanisms and Clinical Applications.
Bachu VS, Kedda J, Suk I, Green JJ, et al · · 2021 · cited 166× · PMID 34374945 · DOI 10.1007/s10439-021-02833-9
Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications.
Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, et al · · 2021 · cited 160× · PMID 33988964 · DOI 10.1021/acsbiomaterials.1c00217
Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes.
Lee BC, Kang I, Yu KR. · · 2021 · cited 124× · PMID 33670202 · DOI 10.3390/jcm10040711
Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering.
Liang Y, Iqbal Z, Lu J, Wang J, et al · · 2023 · cited 99× · PMID 36245129 · DOI 10.1016/j.ymthe.2022.10.008
Functional assays to assess the therapeutic potential of extracellular vesicles.
Nguyen VVT, Witwer KW, Verhaar MC, Strunk D, et al · · 2020 · cited 94× · PMID 33708360 · DOI 10.1002/jev2.12033

Verify or expand the search:

Other trials of Exosomes

Trials testing the same drug.

NCT07382453 — Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases · Phase 2 · not yet recruiting
NCT07565844 — Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic Neuralgia · NA · recruiting

Other recruiting trials for Neuralgia

Currently open trials in the same condition.

NCT06398847 — Virtual Reality (VR) Self-Hypnosis Software · NA · recruiting
NCT06796595 — Perioperative Medical Program to Optimize Nerve Regeneration After Robot-assisted Laparoscopic Neurolyses of Pudendal an · recruiting
NCT05817786 — Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots · NA · recruiting

Other Neurological Associates of West Los Angeles trials

Trials by the same sponsor.

NCT05970575 — Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury · Phase 2 · terminated
NCT04209023 — The Use of Navigated Transcranial Magnetic Stimulation (nTMS) in the Inhibition of Neurofunctional Regions of Interest · NA · suspended
NCT04770350 — Open Label Study for the Use of Transcranial Ultrasound for Treatment of Age-Related Frailty · EARLY_PHASE1 · unknown
NCT05041088 — Omega 3 Oil: Aging-Related Cognitive Decline · Phase 1 · unknown
NCT05475340 — Open Label Study for the Use of Transcranial Ultrasound Treatment of Tremor · EARLY_PHASE1 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04202783 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Neurological Associates of West Los Angeles
Last refreshed: 28 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04202783.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing